K260281Substantially Equivalent
VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)
bioMerieux, Inc., Hazelwood MO / Traditional, Substantially Equivalent
K260281 is the FDA 510(k) clearance record for VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL), a class II device, cleared for BIOMERIEUX on under FDA product code LON (System, Test, Automated, Antimicrobial Susceptibility, Short Incubation). FDA records list 408 510(k) clearances for BIOMERIEUX, from to . As of , FDA records show no recalls naming K260281.
Clearance record
- Decision date
- Received
- (56 days to decision)
- Product code
- LON System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
- Regulation
- 21 CFR 866.1645
- Device class
- Class II
- Review panel
- Microbiology
- Applicant
- Biomerieux 595 Anglum Rd., Hazelwood MO
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code LON
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 1 |
| April 2026 | 1 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
